Cargando…

Characteristics of COPD Phenotypes in Serbia

BACKGROUND: Establishing a regional/national/international registry of patients suffering from chronic obstructive pulmonary disease (COPD) is essential for both research and healthcare, because it enables collection of comprehensive real-life data from a large number of individuals. OBJECTIVE: The...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazic, Zorica, Stankovic, Ivana, Milenkovic, Branislava, Zvezdin, Biljana, Hromis, Sanja, Jankovic, Slobodan, Cupurdija, Vojislav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981162/
https://www.ncbi.nlm.nih.gov/pubmed/33758501
http://dx.doi.org/10.2147/COPD.S300693
_version_ 1783667502923907072
author Lazic, Zorica
Stankovic, Ivana
Milenkovic, Branislava
Zvezdin, Biljana
Hromis, Sanja
Jankovic, Slobodan
Cupurdija, Vojislav
author_facet Lazic, Zorica
Stankovic, Ivana
Milenkovic, Branislava
Zvezdin, Biljana
Hromis, Sanja
Jankovic, Slobodan
Cupurdija, Vojislav
author_sort Lazic, Zorica
collection PubMed
description BACKGROUND: Establishing a regional/national/international registry of patients suffering from chronic obstructive pulmonary disease (COPD) is essential for both research and healthcare, because it enables collection of comprehensive real-life data from a large number of individuals. OBJECTIVE: The aim of this study was to describe characteristics of COPD patients from the Serbian patient registry, and to investigate actual differences of those characteristics among the COPD phenotypes. METHODS: The Serbian registry of patients with COPD was established in 2018 at University of Kragujevac, Faculty of Medical Sciences, based on an online platform. Entry in the Registry was allowed for patients who were diagnosed with COPD according to the following criteria: symptoms of dyspnea, chronic cough or sputum production, history of risk factors for COPD and any degree of persistent airflow limitation diagnosed at spirometry. RESULTS: In the Serbian COPD registry B and D GOLD group were dominant, while among the COPD phenotypes, the most prevalent were non-exacerbators (49.4%) and then frequent exacerbators without chronic bronchitis (29.6%). The frequent exacerbator with chronic bronchitis phenotype was associated with low levels of bronchopulmonary function and absolute predominance of GOLD D group. Anxiety, depression, insomnia, hypertension and chronic heart failure were the most prevalent in the frequent exacerbator with chronic bronchitis phenotype; patients with this phenotype were also treated more frequently than other patients with a triple combination of the most effective inhaled anti-obstructive drugs: long-acting muscarinic antagonists, long-acting beta 2 agonists and corticosteroids. CONCLUSION: In conclusion, the data from the Serbian registry are in line with those from other national registries, showing that frequent exacerbators with chronic bronchitis have worse bronchopulmonary function, more severe signs and symptoms, and more comorbidities (especially anxiety and depression) than other phenotypes. Other studies also confirmed worse quality of life and worse prognosis of the AE-CB phenotype, stressing importance of both preventive and appropriate therapeutic measures against chronic bronchitis.
format Online
Article
Text
id pubmed-7981162
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-79811622021-03-22 Characteristics of COPD Phenotypes in Serbia Lazic, Zorica Stankovic, Ivana Milenkovic, Branislava Zvezdin, Biljana Hromis, Sanja Jankovic, Slobodan Cupurdija, Vojislav Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND: Establishing a regional/national/international registry of patients suffering from chronic obstructive pulmonary disease (COPD) is essential for both research and healthcare, because it enables collection of comprehensive real-life data from a large number of individuals. OBJECTIVE: The aim of this study was to describe characteristics of COPD patients from the Serbian patient registry, and to investigate actual differences of those characteristics among the COPD phenotypes. METHODS: The Serbian registry of patients with COPD was established in 2018 at University of Kragujevac, Faculty of Medical Sciences, based on an online platform. Entry in the Registry was allowed for patients who were diagnosed with COPD according to the following criteria: symptoms of dyspnea, chronic cough or sputum production, history of risk factors for COPD and any degree of persistent airflow limitation diagnosed at spirometry. RESULTS: In the Serbian COPD registry B and D GOLD group were dominant, while among the COPD phenotypes, the most prevalent were non-exacerbators (49.4%) and then frequent exacerbators without chronic bronchitis (29.6%). The frequent exacerbator with chronic bronchitis phenotype was associated with low levels of bronchopulmonary function and absolute predominance of GOLD D group. Anxiety, depression, insomnia, hypertension and chronic heart failure were the most prevalent in the frequent exacerbator with chronic bronchitis phenotype; patients with this phenotype were also treated more frequently than other patients with a triple combination of the most effective inhaled anti-obstructive drugs: long-acting muscarinic antagonists, long-acting beta 2 agonists and corticosteroids. CONCLUSION: In conclusion, the data from the Serbian registry are in line with those from other national registries, showing that frequent exacerbators with chronic bronchitis have worse bronchopulmonary function, more severe signs and symptoms, and more comorbidities (especially anxiety and depression) than other phenotypes. Other studies also confirmed worse quality of life and worse prognosis of the AE-CB phenotype, stressing importance of both preventive and appropriate therapeutic measures against chronic bronchitis. Dove 2021-03-16 /pmc/articles/PMC7981162/ /pubmed/33758501 http://dx.doi.org/10.2147/COPD.S300693 Text en © 2021 Lazic et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Lazic, Zorica
Stankovic, Ivana
Milenkovic, Branislava
Zvezdin, Biljana
Hromis, Sanja
Jankovic, Slobodan
Cupurdija, Vojislav
Characteristics of COPD Phenotypes in Serbia
title Characteristics of COPD Phenotypes in Serbia
title_full Characteristics of COPD Phenotypes in Serbia
title_fullStr Characteristics of COPD Phenotypes in Serbia
title_full_unstemmed Characteristics of COPD Phenotypes in Serbia
title_short Characteristics of COPD Phenotypes in Serbia
title_sort characteristics of copd phenotypes in serbia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981162/
https://www.ncbi.nlm.nih.gov/pubmed/33758501
http://dx.doi.org/10.2147/COPD.S300693
work_keys_str_mv AT laziczorica characteristicsofcopdphenotypesinserbia
AT stankovicivana characteristicsofcopdphenotypesinserbia
AT milenkovicbranislava characteristicsofcopdphenotypesinserbia
AT zvezdinbiljana characteristicsofcopdphenotypesinserbia
AT hromissanja characteristicsofcopdphenotypesinserbia
AT jankovicslobodan characteristicsofcopdphenotypesinserbia
AT cupurdijavojislav characteristicsofcopdphenotypesinserbia